Shimada Shingo, Kamiyama Toshiya, Kakisaka Tatsuhiko, Orimo Tatsuya, Nagatsu Akihisa, Asahi Yoh, Sakamoto Yuzuru, Abo Daisuke, Kamachi Hirofumi, Taketomi Akinobu
Department of Gastroenterological Surgery I Hokkaido University Graduate School of Medicine Sapporo Japan.
Department of Diagnostic Imaging Hokkaido University Graduate School of Medicine Sapporo Japan.
JGH Open. 2020 Oct 30;5(1):41-49. doi: 10.1002/jgh3.12444. eCollection 2021 Jan.
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (EOB-MRI) has been recognized as a useful imaging technique to distinguish the biological behavior of hepatocellular carcinoma (HCC).
We analyzed 217 hepatectomy recipients with HCCs measuring 10 cm or less. We divided the patients into a decreased intensity (DI) group ( = 189, 87%) and an increased or neutral intensity (INI) group ( = 28, 13%) according to the ratio of tumor intensity to liver intensity during the hepatobiliary phase (HBP). According to the ratio of the maximum tumor diameter (including peritumoral hypointensity) between HBP images and precontrast T1-weighted images (RHBPP), we divided the patients as follows: The group whose RHBPP was ≥1.036 was the high RHBPP group ( = 60, 28%), and the group whose RHBPP was <1.036 was the low RHBPP group ( = 157, 72%). We investigated the prognoses and clinicopathological characteristics of these patients.
DI INI was not a prognostic factor for either survival or recurrence; however, a high RHBPP was an independent predictor of unfavorable survival and recurrence in patients. In addition, the INI group showed significantly lower α-fetoprotein (AFP) levels and higher rates of well-differentiated HCC and ICGR15 ≥15% than the DI group. The high RHBPP group showed significantly higher rates of vascular invasion and poorly differentiated HCC than the low RHBPP group.
A high RHBPP by EOB-MRI is a preoperative predictor of vascular invasion and an unfavorable prognostic factor for survival and recurrence. These patients might be considered for highly curative operations such as anatomical liver resection.
钆塞酸二钠(Gd-EOB-DTPA)增强磁共振成像(EOB-MRI)已被公认为是一种区分肝细胞癌(HCC)生物学行为的有用成像技术。
我们分析了217例接受肝切除术的HCC患者,肿瘤直径均在10 cm及以下。根据肝胆期(HBP)肿瘤与肝脏的信号强度比,将患者分为信号强度降低(DI)组(n = 189,87%)和信号强度增加或不变(INI)组(n = 28,13%)。根据HBP图像与对比剂注射前T1加权图像之间的最大肿瘤直径(包括瘤周低信号)之比(RHBPP),将患者分为以下两组:RHBPP≥1.036的为高RHBPP组(n = 60,28%),RHBPP<1.036的为低RHBPP组(n = 157,72%)。我们研究了这些患者的预后和临床病理特征。
DI与INI无论是对生存还是复发均不是预后因素;然而,高RHBPP是患者生存不良和复发的独立预测因素。此外,INI组的甲胎蛋白(AFP)水平显著低于DI组,高分化HCC和ICGR15≥15%的比例高于DI组。高RHBPP组的血管侵犯率和低分化HCC的比例显著高于低RHBPP组。
EOB-MRI检测到的高RHBPP是血管侵犯的术前预测指标,也是生存和复发的不良预后因素。对于这些患者,可考虑进行如解剖性肝切除等高根治性手术。